Provided by Tiger Trade Technology Pte. Ltd.

Kiniksa Pharmaceuticals Ltd.

78.15
+0.35000.45%
Pre-market: 78.450.3000+0.38%07:35 EDT
Volume:527.79K
Turnover:41.41M
Market Cap:6.10B
PE:78.94
High:79.79
Open:77.37
Low:76.92
Close:77.80
52wk High:82.94
52wk Low:32.69
Shares:78.02M
Float Shares:42.53M
Volume Ratio:1.53
T/O Rate:1.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9900
EPS(LYR):0.7500
ROE:14.04%
ROA:8.05%
PB:9.32
PE(LYR):104.20

Loading ...

Does Raised 2026 Revenue Guidance Change The Bull Case For Kiniksa Pharmaceuticals International (KNSA)?

Simply Wall St.
·
Aug 09

Kiniksa Pharmaceuticals to Present at Canaccord Genuity Annual Growth Conference

Reuters
·
Aug 08

Kiniksa Director Cole G. Bradley Disposes of 3,673 Shares for $299,693.39

Reuters
·
Aug 01

Agios Q2 Revenue Jumps on US Commercial Launch of Aqvesme

Reuters
·
Jul 30

Kiniksa price target raised to $90 from $75 at Goldman Sachs

TIPRANKS
·
Jul 30

Genius Sports Stock And Two Growth Names Worth Watching

Simply Wall St.
·
Jul 30

Kiniksa Pharmaceuticals is Maintained at Outperform by Wedbush

Dow Jones
·
Jul 30

Kiniksa Pharmaceuticals International, Plc : Jefferies Raises Target Price to $108 from $78

THOMSON REUTERS
·
Jul 29

Top Midday Gainers

MT Newswires Live
·
Jul 29

Kiniksa rises 23.9%

TIPRANKS
·
Jul 29

Kiniksa's Arcalyst Growth Outlook Strengthens, Wedbush Says

MT Newswires Live
·
Jul 28

Analysts’ Top Healthcare Picks: Kiniksa Pharmaceuticals (KNSA), Cullinan Management (CGEM)

TIPRANKS
·
Jul 28

Kiniksa Pharmaceuticals International, Plc : TD Cowen Raises Target Price to $95 from $65

THOMSON REUTERS
·
Jul 28

Wedbush Raises Price Target on Kiniksa Pharmaceuticals to $99 From $72, Maintains Outperform Rating

MT Newswires Live
·
Jul 28

Kiniksa Pharmaceuticals International, PLC Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 28

Nautilus Biotechnology Posts First Revenue, Q2 Net Loss Narrows

Reuters
·
Jul 28

Kiniksa Pharmaceuticals International Q2 Net Income, Revenue Increase

MT Newswires Live
·
Jul 28

Kiniksa Pharmaceuticals Q2 Product Revenue Rises on Arcalyst Sales

Reuters
·
Jul 28

Earnings Flash (KNSA) Kiniksa Pharmaceuticals Posts Q2 EPS $0.30, vs. FactSet Est of $0.28

MT Newswires Live
·
Jul 28

Kiniksa Q2 FY26 Net Income Rises 42.7% to $25.4 Million; Revenue Climbs 55.4% to $243.6 Million

Reuters
·
Jul 28